Form 4 for ATYR aTYR PHARMA INC
Accepted 2022-01-18 00:00:00 ET · period of report 2022-01-13 · accession 0001209191-22-003419 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-18 | 2022-01-13 | ATYR | Broadfoot Jill Marie | CFO | P - Purchase | $6.75 | +1,923 | 12.1K | +19% | +$13.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2022-01-13 | P | A | 1,923 | $6.75 | 12,112 | D | — | — | (F1) Includes 178 shares acquired under the Company's 2015 Employee Stock Purchase Plan on November 15, 2021. |